Hereditary Angioedema Treatment Market
1 Study Coverage
1.1 Hereditary Angioedema Treatment Product Introduction
1.2 Global Hereditary Angioedema Treatment Outlook 2017 VS 2022 VS 2028
1.2.1 Global Hereditary Angioedema Treatment Sales in US$ Million for the Year 2017-2028
1.2.2 Global Hereditary Angioedema Treatment Sales in Volume for the Year 2017-2028
1.3 United States Hereditary Angioedema Treatment Outlook 2017 VS 2022 VS 2028
1.3.1 United States Hereditary Angioedema Treatment Sales in US$ Million for the Year 2017-2028
1.3.2 United States Hereditary Angioedema Treatment Sales in Volume for the Year 2017-2028
1.4 Hereditary Angioedema Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Hereditary Angioedema Treatment in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Hereditary Angioedema Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Hereditary Angioedema Treatment Market Dynamics
1.5.1 Hereditary Angioedema Treatment Industry Trends
1.5.2 Hereditary Angioedema Treatment Market Drivers
1.5.3 Hereditary Angioedema Treatment Market Challenges
1.5.4 Hereditary Angioedema Treatment Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Hereditary Angioedema Treatment Market Segment by Type
2.1.1 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
2.1.2 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
2.1.3 Kallikrein Inhibitors (Kalbitor, Takhzyro)
2.1.4 Others (Conventional Drugs, Pipeline Drugs)
2.2 Global Hereditary Angioedema Treatment Market Size by Type
2.2.1 Global Hereditary Angioedema Treatment Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Hereditary Angioedema Treatment Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Hereditary Angioedema Treatment Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Hereditary Angioedema Treatment Market Size by Type
2.3.1 United States Hereditary Angioedema Treatment Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Hereditary Angioedema Treatment Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Hereditary Angioedema Treatment Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Hereditary Angioedema Treatment Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Others (online pharmacies, mail pharmacies)
3.2 Global Hereditary Angioedema Treatment Market Size by Application
3.2.1 Global Hereditary Angioedema Treatment Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Hereditary Angioedema Treatment Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Hereditary Angioedema Treatment Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Hereditary Angioedema Treatment Market Size by Application
3.3.1 United States Hereditary Angioedema Treatment Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Hereditary Angioedema Treatment Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Hereditary Angioedema Treatment Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Hereditary Angioedema Treatment Competitor Landscape by Company
4.1 Global Hereditary Angioedema Treatment Market Size by Company
4.1.1 Top Global Hereditary Angioedema Treatment Manufacturers Ranked by Revenue (2021)
4.1.2 Global Hereditary Angioedema Treatment Revenue by Manufacturer (2017-2022)
4.1.3 Global Hereditary Angioedema Treatment Sales by Manufacturer (2017-2022)
4.1.4 Global Hereditary Angioedema Treatment Price by Manufacturer (2017-2022)
4.2 Global Hereditary Angioedema Treatment Concentration Ratio (CR)
4.2.1 Hereditary Angioedema Treatment Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Hereditary Angioedema Treatment in 2021
4.2.3 Global Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Hereditary Angioedema Treatment Manufacturing Base Distribution, Product Type
4.3.1 Global Hereditary Angioedema Treatment Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Hereditary Angioedema Treatment Product Type
4.3.3 Date of International Manufacturers Enter into Hereditary Angioedema Treatment Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Hereditary Angioedema Treatment Market Size by Company
4.5.1 Top Hereditary Angioedema Treatment Players in United States, Ranked by Revenue (2021)
4.5.2 United States Hereditary Angioedema Treatment Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Hereditary Angioedema Treatment Sales by Players (2020, 2021 & 2022)
5 Global Hereditary Angioedema Treatment Market Size by Region
5.1 Global Hereditary Angioedema Treatment Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Hereditary Angioedema Treatment Market Size in Volume by Region (2017-2028)
5.2.1 Global Hereditary Angioedema Treatment Sales in Volume by Region: 2017-2022
5.2.2 Global Hereditary Angioedema Treatment Sales in Volume Forecast by Region (2023-2028)
5.3 Global Hereditary Angioedema Treatment Market Size in Value by Region (2017-2028)
5.3.1 Global Hereditary Angioedema Treatment Sales in Value by Region: 2017-2022
5.3.2 Global Hereditary Angioedema Treatment Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Hereditary Angioedema Treatment Market Size YoY Growth 2017-2028
6.1.2 North America Hereditary Angioedema Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Hereditary Angioedema Treatment Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Hereditary Angioedema Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Hereditary Angioedema Treatment Market Size YoY Growth 2017-2028
6.3.2 Europe Hereditary Angioedema Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Hereditary Angioedema Treatment Market Size YoY Growth 2017-2028
6.4.2 Latin America Hereditary Angioedema Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Hereditary Angioedema Treatment Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Hereditary Angioedema Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 CSL
7.1.1 CSL Corporation Information
7.1.2 CSL Description and Business Overview
7.1.3 CSL Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2017-2022)
7.1.4 CSL Hereditary Angioedema Treatment Products Offered
7.1.5 CSL Recent Development
7.2 Pharming Group
7.2.1 Pharming Group Corporation Information
7.2.2 Pharming Group Description and Business Overview
7.2.3 Pharming Group Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Pharming Group Hereditary Angioedema Treatment Products Offered
7.2.5 Pharming Group Recent Development
7.3 Shire plc (Takeda Pharmaceutical Company Limited)
7.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Corporation Information
7.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Description and Business Overview
7.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Products Offered
7.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Recent Development
7.4 Ionis Pharmaceuticals
7.4.1 Ionis Pharmaceuticals Corporation Information
7.4.2 Ionis Pharmaceuticals Description and Business Overview
7.4.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Ionis Pharmaceuticals Hereditary Angioedema Treatment Products Offered
7.4.5 Ionis Pharmaceuticals Recent Development
7.5 Attune Pharmaceuticals
7.5.1 Attune Pharmaceuticals Corporation Information
7.5.2 Attune Pharmaceuticals Description and Business Overview
7.5.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Attune Pharmaceuticals Hereditary Angioedema Treatment Products Offered
7.5.5 Attune Pharmaceuticals Recent Development
7.6 BioCryst Pharmaceuticals
7.6.1 BioCryst Pharmaceuticals Corporation Information
7.6.2 BioCryst Pharmaceuticals Description and Business Overview
7.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2017-2022)
7.6.4 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Products Offered
7.6.5 BioCryst Pharmaceuticals Recent Development
7.7 KalVista Pharmaceuticals
7.7.1 KalVista Pharmaceuticals Corporation Information
7.7.2 KalVista Pharmaceuticals Description and Business Overview
7.7.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2017-2022)
7.7.4 KalVista Pharmaceuticals Hereditary Angioedema Treatment Products Offered
7.7.5 KalVista Pharmaceuticals Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Hereditary Angioedema Treatment Industry Chain Analysis
8.2 Hereditary Angioedema Treatment Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Hereditary Angioedema Treatment Distributors
8.3 Hereditary Angioedema Treatment Production Mode & Process
8.4 Hereditary Angioedema Treatment Sales and Marketing
8.4.1 Hereditary Angioedema Treatment Sales Channels
8.4.2 Hereditary Angioedema Treatment Distributors
8.5 Hereditary Angioedema Treatment Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Hereditary Angioedema Treatment CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Hereditary Angioedema Treatment Market Trends
Table 3. Hereditary Angioedema Treatment Market Drivers
Table 4. Hereditary Angioedema Treatment Market Challenges
Table 5. Hereditary Angioedema Treatment Market Restraints
Table 6. Global Hereditary Angioedema Treatment Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Hereditary Angioedema Treatment Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Hereditary Angioedema Treatment Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Hereditary Angioedema Treatment Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Hereditary Angioedema Treatment Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Hereditary Angioedema Treatment Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Hereditary Angioedema Treatment Revenue Share by Manufacturer, 2017-2022
Table 13. Global Hereditary Angioedema Treatment Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Hereditary Angioedema Treatment Sales Share by Manufacturer, 2017-2022
Table 15. Global Hereditary Angioedema Treatment Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Hereditary Angioedema Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Hereditary Angioedema Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Treatment as of 2021)
Table 18. Top Players of Hereditary Angioedema Treatment in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Hereditary Angioedema Treatment Product Type
Table 20. Date of International Manufacturers Enter into Hereditary Angioedema Treatment Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Hereditary Angioedema Treatment Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Hereditary Angioedema Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Hereditary Angioedema Treatment Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Hereditary Angioedema Treatment Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Hereditary Angioedema Treatment Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Hereditary Angioedema Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Hereditary Angioedema Treatment Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Hereditary Angioedema Treatment Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Hereditary Angioedema Treatment Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Hereditary Angioedema Treatment Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Hereditary Angioedema Treatment Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Hereditary Angioedema Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Hereditary Angioedema Treatment Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Hereditary Angioedema Treatment Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Hereditary Angioedema Treatment Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Hereditary Angioedema Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Hereditary Angioedema Treatment Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Hereditary Angioedema Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Hereditary Angioedema Treatment Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Hereditary Angioedema Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. CSL Corporation Information
Table 43. CSL Description and Business Overview
Table 44. CSL Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. CSL Hereditary Angioedema Treatment Product
Table 46. CSL Recent Development
Table 47. Pharming Group Corporation Information
Table 48. Pharming Group Description and Business Overview
Table 49. Pharming Group Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Pharming Group Product
Table 51. Pharming Group Recent Development
Table 52. Shire plc (Takeda Pharmaceutical Company Limited) Corporation Information
Table 53. Shire plc (Takeda Pharmaceutical Company Limited) Description and Business Overview
Table 54. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Shire plc (Takeda Pharmaceutical Company Limited) Product
Table 56. Shire plc (Takeda Pharmaceutical Company Limited) Recent Development
Table 57. Ionis Pharmaceuticals Corporation Information
Table 58. Ionis Pharmaceuticals Description and Business Overview
Table 59. Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Ionis Pharmaceuticals Product
Table 61. Ionis Pharmaceuticals Recent Development
Table 62. Attune Pharmaceuticals Corporation Information
Table 63. Attune Pharmaceuticals Description and Business Overview
Table 64. Attune Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Attune Pharmaceuticals Product
Table 66. Attune Pharmaceuticals Recent Development
Table 67. BioCryst Pharmaceuticals Corporation Information
Table 68. BioCryst Pharmaceuticals Description and Business Overview
Table 69. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. BioCryst Pharmaceuticals Product
Table 71. BioCryst Pharmaceuticals Recent Development
Table 72. KalVista Pharmaceuticals Corporation Information
Table 73. KalVista Pharmaceuticals Description and Business Overview
Table 74. KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. KalVista Pharmaceuticals Product
Table 76. KalVista Pharmaceuticals Recent Development
Table 77. Key Raw Materials Lists
Table 78. Raw Materials Key Suppliers Lists
Table 79. Hereditary Angioedema Treatment Customers List
Table 80. Hereditary Angioedema Treatment Distributors List
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Hereditary Angioedema Treatment Product Picture
Figure 2. Global Hereditary Angioedema Treatment Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Hereditary Angioedema Treatment Market Size 2017-2028 (US$ Million)
Figure 4. Global Hereditary Angioedema Treatment Sales 2017-2028 (K Units)
Figure 5. United States Hereditary Angioedema Treatment Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Hereditary Angioedema Treatment Market Size 2017-2028 (US$ Million)
Figure 7. United States Hereditary Angioedema Treatment Sales 2017-2028 (K Units)
Figure 8. United States Hereditary Angioedema Treatment Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Hereditary Angioedema Treatment Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Hereditary Angioedema Treatment Report Years Considered
Figure 11. Product Picture of C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Figure 12. Product Picture of Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Figure 13. Product Picture of Kallikrein Inhibitors (Kalbitor, Takhzyro)
Figure 14. Product Picture of Others (Conventional Drugs, Pipeline Drugs)
Figure 15. Global Hereditary Angioedema Treatment Market Share by Type in 2022 & 2028
Figure 16. Global Hereditary Angioedema Treatment Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global Hereditary Angioedema Treatment Sales Market Share in Value by Type (2017-2028)
Figure 18. Global Hereditary Angioedema Treatment Sales by Type (2017-2028) & (K Units)
Figure 19. Global Hereditary Angioedema Treatment Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global Hereditary Angioedema Treatment Price by Type (2017-2028) & (USD/Unit)
Figure 21. United States Hereditary Angioedema Treatment Market Share by Type in 2022 & 2028
Figure 22. United States Hereditary Angioedema Treatment Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States Hereditary Angioedema Treatment Sales Market Share in Value by Type (2017-2028)
Figure 24. United States Hereditary Angioedema Treatment Sales by Type (2017-2028) & (K Units)
Figure 25. United States Hereditary Angioedema Treatment Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States Hereditary Angioedema Treatment Price by Type (2017-2028) & (USD/Unit)
Figure 27. Product Picture of Hospital Pharmacies
Figure 28. Product Picture of Retail Pharmacies
Figure 29. Product Picture of Others (online pharmacies, mail pharmacies)
Figure 30. Global Hereditary Angioedema Treatment Market Share by Application in 2022 & 2028
Figure 31. Global Hereditary Angioedema Treatment Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Hereditary Angioedema Treatment Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Hereditary Angioedema Treatment Sales by Application (2017-2028) & (K Units)
Figure 34. Global Hereditary Angioedema Treatment Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Hereditary Angioedema Treatment Price by Application (2017-2028) & (USD/Unit)
Figure 36. United States Hereditary Angioedema Treatment Market Share by Application in 2022 & 2028
Figure 37. United States Hereditary Angioedema Treatment Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Hereditary Angioedema Treatment Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Hereditary Angioedema Treatment Sales by Application (2017-2028) & (K Units)
Figure 40. United States Hereditary Angioedema Treatment Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Hereditary Angioedema Treatment Price by Application (2017-2028) & (USD/Unit)
Figure 42. North America Hereditary Angioedema Treatment Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 43. North America Hereditary Angioedema Treatment Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Hereditary Angioedema Treatment Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 47. Europe Hereditary Angioedema Treatment Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Hereditary Angioedema Treatment Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 54. Asia-Pacific Hereditary Angioedema Treatment Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Taiwan Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Latin America Hereditary Angioedema Treatment Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 66. Latin America Hereditary Angioedema Treatment Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 67. Mexico Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Brazil Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Argentina Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa Hereditary Angioedema Treatment Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 71. Middle East & Africa Hereditary Angioedema Treatment Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. U.A.E Hereditary Angioedema Treatment Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Hereditary Angioedema Treatment Value Chain
Figure 76. Hereditary Angioedema Treatment Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
Industry Market Size
